Interim analysis of a real-world retrospective multicenter study: Evaluation of effectiveness of secukinumab in adult patients with moderate-to-severe plaque psoriasis in China

被引：0
|
作者：
Liu, N. [1 ]
Xiao, X. [4 ]
Pan, R. [4 ]
Li, W. [3 ]
Yang, B. [2 ]
Shi, Y. [1 ]
机构：
[1] Shanghai Skin Dis Hosp, Shanghai, Peoples R China
[2] Southern Med Univ, Dermatol Hosp, Guangzhou, Peoples R China
[3] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
[4] Beijing Novartis Pharma Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2021年 / 141卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
399
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [1] Treatment outcomes of secukinumab in adult patients with moderate-to-severe plaque psoriasis in China: A real-world multicenter retrospective study
    Ding, Yangfeng
    Li, Wei
    Guan, Xin
    Liu, Na
    Zhou, Ying
    Li, Gaojie
    Wang, Xiaohua
    Wang, Zhidong
    Xiao, Xiao
    Yang, Bin
    Lv, Chengzhi
    Zhang, Chunlei
    Shi, Yuling
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (10): : 1803 - 1814
  • [2] Real-World Effectiveness and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis in Adult Patients: A 52-Week Multicenter Retrospective Study
    Yeung, Jensen
    Sood, Siddhartha
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024,
  • [3] Effectiveness and safety of secukinumab in patients with moderate-to-severe plaque psoriasis - a real life retrospective study
    Galica, Katarzyna
    Lesiak, Aleksandra
    Ciazynska, Magdalena
    Noweta, Marcin
    Bednarski, Igor
    Narbutt, Joanna
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2021, 38 (06): : 973 - 978
  • [4] Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: real-world data from a retrospective multicenter study
    Topal, Ilteris Oguz
    Baysak, Sevim
    Altunay, Ilknur Kivanc
    Polat, Asude Kara
    Arikan, Eylem Emel
    Ozkur, Ezgi
    Aytekin, Sema
    Dogan, Bilal
    Akbulut, Tugba Ozkok
    Demir, Filiz Topaloglu
    Karadag, Ayse Serap
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2022, 97 (05) : 566 - 574
  • [5] Real-World Effectiveness of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis in Canada
    Abu-Hilal, Mohannad
    Cowger, Jeff
    Bawazir, Mohammed
    Sajic, Dusan
    Savinova, Iryna
    Yap, Belinda
    El-Sayegh, Rami
    Bolatova, Talshyn
    Chan, Pak
    Cy, Ajith
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024,
  • [6] Secukinumab demonstrates sustained effectiveness in treating patients with moderate-to-severe plaque psoriasis: real-world evidence from Canada
    Papp, K. A.
    Gooderham, M.
    Delorme, I.
    Lomaga, M.
    Robern, M.
    Hernandez, M. A.
    Taraska, V.
    Ho, V.
    Vieira, A.
    Rihakova, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 44 - 45
  • [7] Effectiveness and safety of secukinumab in 69 patients with moderate to severe plaque psoriasis: A retrospective multicenter study
    Schwensen, J. F.
    Clemmensen, A.
    Sand, C.
    Gniadecki, R.
    Skov, L.
    Zachariae, C.
    Iversen, L.
    Rasmussen, M.
    Thomsen, S. F.
    DERMATOLOGIC THERAPY, 2017, 30 (06)
  • [8] Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real-world practice
    Zhou, Jian
    Yuan, Yuan
    Liu, Yanhua
    Chu, Mengyang
    Liu, Huan
    Liu, Qian
    Wang, Rui
    Shao, Shuai
    Wang, Gang
    Yu, Chen
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (01)
  • [9] Real-World Experience of Secukinumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis in Greece: 3-Year Interim Results of the SERENA Study
    Ioannides, Dimitrios
    Rigopoulos, Dimitrios
    Papakonstantis, Markos
    Chasapi, Vasiliki
    Deligiannis, Panagiotis
    Rigatos, Panagiotis
    Lefaki, Ioanna
    Papadavid, Evangelia
    Pokas, Eteoklis
    Tsilifis, Spyridon
    Roussaki-Schulze, Angeliki-Viktoria
    Barkis, Ioannis
    Lazaridou, Elisabeth
    Fotiadou, Christina
    Zisimou, Chrysa
    Kallidis, Panagiotis
    Chatzakis, Vasileios
    Oikonomou, Chrysa
    Madia, Xenia
    DERMATOLOGIC THERAPY, 2024, 2024
  • [10] A Retrospective Real-World Study of the Effectiveness and Tolerability of Tildrakizumab in UK Adults with Moderate-to-Severe Chronic Plaque Psoriasis
    Becher, Gabrielle
    Conner, Sophia
    Ingram, Jennifer A.
    Stephen, Karen E.
    McInnes, Alison C.
    Heald, Adrian H.
    Riley, Paul A.
    Davies, Mark
    Domenech, Arnau
    Kasujee, Ismail
    DERMATOLOGY AND THERAPY, 2022, 12 (10) : 2343 - 2354
12345